I believe it would take a commercial deal with upfront cash content to eclipse the IPO price.
You know Biotechs go into the dreaded Trial Phases , Investors lose interest, you end up with a steady decline from bugger all news, then you gain a couple of spikes on positive data, then a commercial deal arrives and we wish we had filled up a suitcase of shares...
I see an easy climb to 14/15 in the near term... remember BDX has already climbed back 50% in a month... some Bio's are languishing so it would demonstrate the market understand BDX's offering
These Diagnostic tests cost in the pennies to manufacture ,, they certainly get rolled out to market with several 100% cream......
I'm a fixed margin Trader so I'm not shooting for the moon off the back of Bio's ..
Not advice by any stretch but hope it helps?
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
Add BDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.010(6.90%) |
Mkt cap ! $42.42M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.0¢ | 13.5¢ | $21.94K | 158.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 333083 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 96787 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| BDX (ASX) Chart |